Enfusion, Inc.

CIK 1868912 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enfusion, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2025SCHEDULE 13G/A0001398344-25-009595
May 15, 2025SCHEDULE 13G/A0000950170-25-072044
May 1, 202515-12G0001193125-25-109983
Apr 23, 202540000950170-25-057455
Apr 23, 2025EFFECT9999999995-25-001196
Apr 23, 202540000950170-25-057454
Apr 21, 2025SCHEDULE 13G/A0001104659-25-036884
Apr 21, 2025S-8 POS0001104659-25-036875
Apr 21, 202540001104659-25-036895
Apr 21, 202540001104659-25-036905
Apr 21, 202540001104659-25-036900
Apr 21, 2025SCHEDULE 13G/A0001104659-25-036882
Apr 21, 202540001104659-25-036889
Apr 21, 2025S-8 POS0001104659-25-036876
Apr 21, 2025SCHEDULE 13G/A0001104659-25-036881
Apr 21, 202540001104659-25-036909
Apr 21, 2025SCHEDULE 13G/A0001104659-25-036887
Apr 21, 202540001104659-25-036912
Apr 21, 20258-K0001104659-25-036869
Apr 21, 202540001104659-25-036890
Apr 21, 202540001104659-25-036902
Apr 21, 2025S-8 POS0001104659-25-036877
Apr 21, 202540001104659-25-036896
Apr 21, 202510-K/A0001410578-25-000808
Apr 21, 202540001104659-25-036913